FWD GROUP HOLDINGS LIMITED LAUNCH OF TENDER OFFER
Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the […]
Monster Energy’s Diego Lopes Defeats Jean Silva at Noche UFC in Texas
30-Year-Old from Brazil Claims TKO Win in Featherweight Bout, Earns Double $50,000 UFC Bonus Payouts for Fight of the Night and Performance of the Night SAN ANTONIO, Sept. 14, 2025 /PRNewswire/ — What a night for mixed martial arts! Monster Energy congratulates MMA athlete Diego Lopes on defeating Jean Silva in the Main Event fight at Noche UFC […]
JDEnergy en RE+ 2025: Impulsando la innovación en el almacenamiento de energía
XI’AN, China, 15 de septiembre de 2025 /PRNewswire/ — El 9 de septiembre, RE+ 2025 dio inicio en Las Vegas. Como fabricante global de almacenamiento de energía de primer nivel según BNEF y proveedor número uno de almacenamiento de energía comercial e industrial en China, JDEnergy tuvo un debut brillante, presentando sus dos productos estrella: […]
SM named among TIME’s World’s Best Companies for second year
PASAY CITY, Philippines, Sept. 14, 2025 /PRNewswire/ — SM Investments Corporation (SM Investments), the parent firm of the SM group, has once again been recognized by TIME and Statista on the prestigious “World’s Best Companies 2025” list. This marks the second consecutive year that SM Investments has earned a place on the roster, underscoring its […]
EverBridge Group y Cosmotec forjan una alianza histórica
SHANGHÁI, 15 de septiembre de 2025 /PRNewswire/ — EverBridge Group anunció una asociación de comercialización exclusiva con Cosmotec Inc. (una subsidiaria de propiedad absoluta de M3, Inc.; TSE: 2413) para el mercado japonés. Esta colaboración estratégica subraya el liderazgo de EverBridge Group en I+D patentada, un estricto cumplimiento normativo y una colaboración en un ecosistema […]
Armor Health Announces Partnership with Antidote-AI to Revolutionize Correctional Healthcare Landscape
MIAMI, Sept. 14, 2025 /PRNewswire/ — Armor Health (ArmorHealthcare.com), today announced it’s new partnership with Antidote-AI (Antidote-AI.com) as their correctional healthcare technology partner to provide Armor with their powerful AI clinical tools, embedded in Armor’s Insights Analytics technology platform. Powered by Antidote’s AI solution, Armor’s Insights Analytics will tie in objective measures and integrate […]
EverBridge Group et Cosmotec concluent un partenariat historique
SHANGHAI, 15 septembre 2025 /PRNewswire/ — EverBridge Group a annoncé un partenariat de commercialisation exclusif avec Cosmotec Inc. (une filiale à part entière de M3, Inc. ; TSE : 2413) pour le marché japonais. Cette collaboration stratégique souligne le leadership d’EverBridge Group en matière de R&D exclusive, de conformité réglementaire rigoureuse et de collaboration écosystémique […]
Phrontline Biopharma Announces First Patient Dosed in Phase 1 Clinical Trial of TJ101
SHANGHAI and SUZHOU, China, Sept. 14, 2025 /PRNewswire/ — Phrontline Biopharma, a clinical-stage biotechnology company advancing a new generation of Antibody-Drug Conjugates (ADCs), today announced that the first patient has been successfully dosed in its Phase 1 clinical trial of TJ101, the company’s lead asset targeting EGFR/B7-H3 with a proprietary linker-drug technology. “This is a critical milestone for […]
Lion TCR Achieves Triple FDA Milestones with IND Clearance for Chronic Hepatitis B Following Earlier Fast Track and Orphan Drug Designations
SINGAPORE and GUANGZHOU, China, Sept. 14, 2025 /PRNewswire/ — Lion TCR, a clinical-stage biotechnology company pioneering T-cell receptor (TCR)-based therapies, today announced that it has received Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration (FDA) to initiate phase1b/2 clinical trials for its proprietary TCR-T cell therapy, LioCyx-M004, in patients with chronic hepatitis […]
EverBridge Group und Cosmotec schmieden bahnbrechende Partnerschaft
SHANGHAI, 15. September 2025 /PRNewswire/ — Die EverBridge Group gab eine exklusive Vermarktungspartnerschaft mit Cosmotec Inc. (einer hundertprozentigen Tochtergesellschaft von M3, Inc.; TSE: 2413) für den japanischen Markt. Diese strategische Zusammenarbeit unterstreicht die führende Rolle der EverBridge Group in der firmeneigenen Forschung und Entwicklung, der strikten Einhaltung gesetzlicher Vorschriften und der wertorientierten Zusammenarbeit im Ökosystem […]